Study shows that hepatitis C drug EPCLUSA has the potential to inhibit coronaviruses
Columbia Engineering researchers have been developing strategies to cope with the new strain of coronavirus, 2019-nCoV, that has caused a global public health emergency.
Feb 3, 2020
0
14